The impact of angiogenesis inhibitors on survival of patients with small cell lung cancer

The impact of angiogenesis inhibitors on survival of patients with small cell lung cancer

Abstract Background Small cell lung cancer (SCLC) is a highly invasive and lethal neuroendocrine tumor. Antiangiogenic drugs have been reported in the treatment of SCLC. We aimed to provide a comprehensive evaluation of the impact of angiogenic inhibitors on SCLC survival using network meta‐analysis...

Full description

Bibliographic Details
Main Authors: Xiaoshun Shi, Xiaoying Dong, Sylvia Young, Allen Menglin Chen, Xiguang Liu, Zhouxia Zheng, Kailing Huang, Di Lu, Siyang Feng, Grant Morahan, Kaican Cai
Format: Article
Language:English
Published: Wiley 2019-10-01
Series:Cancer Medicine
Subjects:
angiogenesis inhibitors
network meta‐analysis
randomized controlled trial
small cell lung cancer
target drugs
Online Access:https://doi.org/10.1002/cam4.2462

Internet

https://doi.org/10.1002/cam4.2462

Similar Items